Literature DB >> 1628416

In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

C Halma1, M R Daha, L A van Es.   

Abstract

The mononuclear phagocyte system (MPS) is responsible for the elimination of foreign material, effete autologous material and immune complexes. To study the relationship between MPS function and human disease, several test substances have been developed, and used to determine the clearance capacity of the MPS in human subjects in vivo. These test substances and the multitude of factors that influence the elimination of these substances (and complicate the interpretation of the test results) are discussed. Use of these probes has provided important new insights, that may lead to the development of treatment modalities by which MPS function is modified in order to influence disease processes more effectively.

Entities:  

Mesh:

Year:  1992        PMID: 1628416      PMCID: PMC1554409          DOI: 10.1111/j.1365-2249.1992.tb06868.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  65 in total

1.  SPLENIC DESTRUCTION OF RH-SENSITIZED, AND OF HEATED RED CELLS.

Authors:  P CROME; P L MOLLISON
Journal:  Br J Haematol       Date:  1964-04       Impact factor: 6.998

2.  RATE OF REMOVAL FROM THE CIRCULATION OF RED CELLS SENSITIZED WITH DIFFERENT AMOUNTS OF ANTIBODY.

Authors:  P L MOLLISON; P CROME; N C HUGHES-JONES; E ROCHNA
Journal:  Br J Haematol       Date:  1965-07       Impact factor: 6.998

3.  Lack of action of serum opsonins in phagocytosis of inert particles by cells of reticuloendothelial system.

Authors:  G BIOZZI; C STIFFEL; B N HALPERN; D MOUTON
Journal:  Proc Soc Exp Biol Med       Date:  1963-04

4.  Studies of the reticuloendothelial system (RES). II. Changes in the phagocytic capacity of the RES in patients with certain infections.

Authors:  H N WAGNER; M IIO; R B HORNICK
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

5.  The clearance of antigen antibody complexes from the blood by the reticuloendothelial system.

Authors:  B BENACERRAF; M SEBESTYEN; N S COOPER
Journal:  J Immunol       Date:  1959-02       Impact factor: 5.422

6.  Phagocytosis of heat-denatured human serum albumin labelled with 131I and its use as a means of investigating liver blood flow.

Authors:  B BENACERRAF; G BIOZZI; B N HALPERN; C STIFFEL; D MOUTON
Journal:  Br J Exp Pathol       Date:  1957-02

7.  Platelet aggregation: an intermediary mechanism in carbon clearance.

Authors:  W G van Aken; T M Goote; J Vreeken
Journal:  Scand J Haematol       Date:  1968

8.  Activity of the reticuloendothelial system in diseases of altered immunity.

Authors:  N K Salky; D Mills; N R Di Luzio
Journal:  J Lab Clin Med       Date:  1965-12

9.  Exploration of the phagocytic function of the reticuloendothelial system with heat denatured human serum albumin labeled with I131 and application to the measurement of liver blood flow, in normal man and in some pathologic conditions.

Authors:  G BIOZZI; B BENACERRAF; B N HALPERN; C STIFFEL; B HILLEMAND
Journal:  J Lab Clin Med       Date:  1958-02

10.  Elimination of soluble 123I-labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1.

Authors:  C Halma; F C Breedveld; M R Daha; D Blok; J H Evers-Schouten; J Hermans; E K Pauwels; L A van Es
Journal:  Arthritis Rheum       Date:  1991-04
View more
  5 in total

1.  A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse.

Authors:  M D McSweeney; T Wessler; L S L Price; E C Ciociola; L B Herity; J A Piscitelli; W C Zamboni; M G Forest; Y Cao; S K Lai
Journal:  J Control Release       Date:  2018-06-05       Impact factor: 9.776

2.  Beyond Cisplatin: Combination Therapy with Arsenic Trioxide.

Authors:  Ðenana Miodragović; Elden P Swindell; Zohra Sattar Waxali; Abraham Bogachkov; Thomas V O'Halloran
Journal:  Inorganica Chim Acta       Date:  2019-07-24       Impact factor: 3.118

3.  Enhancing subcutaneous injection and target tissue accumulation of nanoparticles via co-administration with macropinocytosis inhibitory nanoparticles (MiNP).

Authors:  Trevor Stack; Yugang Liu; Molly Frey; Sharan Bobbala; Michael Vincent; Evan Scott
Journal:  Nanoscale Horiz       Date:  2021-04-22       Impact factor: 10.989

4.  Bottlebrush Polymer-Conjugated Melittin Exhibits Enhanced Antitumor Activity and Better Safety Profile.

Authors:  Fei Jia; Peiru Chen; Dali Wang; Yehui Sun; Mengqi Ren; Yuyan Wang; Xueyan Cao; Lei Zhang; Yang Fang; Xuyu Tan; Hao Lu; Jiansong Cai; Xueguang Lu; Ke Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2021-09-02       Impact factor: 10.383

Review 5.  Modification of Lipid-Based Nanoparticles: An Efficient Delivery System for Nucleic Acid-Based Immunotherapy.

Authors:  Chi Zhang; Yifan Ma; Jingjing Zhang; Jimmy Chun-Tien Kuo; Zhongkun Zhang; Haotian Xie; Jing Zhu; Tongzheng Liu
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.